Analysis of the disease burden of pancreatitis in China from 1990 to 2019_Chinese Journal of Evidence-Based Medicine

Authors：

JIANG Mengke ^1,2 , LU Zongqing ^1,2 , ZHOU Wuming ^1,2 , LIU Wanjun ^1,2 ,  YANG Min ^1,2

1. The Laboratory of Cardiopulmonary Resuscitation and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P. R. China;
2. The Second Department of Intensive Care Unit, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, P. R. China;

Corresponding author：

YANG Min, Email: yangmin@ahmu.edu.cn

Keywords：

Pancreatitis; Incidence; Mortality; Burden of disease

DOI：

10.7507/1672-2531.202203063

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective This study aimed to analyze the disease burden of pancreatitis in China from 1990 to 2019 and to provide references for the prevention and treatment of pancreatitis. Methods The data were obtained from the Global Burden of Disease Study 2019 (GBD 2019). The incidence, mortality, disability-adjusted life years (DALYs), years of life lost (YLLs), years lived with disability (YLDs) and their corresponding age-standardized rate, and annual average percentage change (AAPC) were selected as the main indicators to compare the burden of pancreatitis in China, the United States and globally from 1990 to 2019. Results In 2019, the age-standardized incidence, mortality, DALY, YLL, and YLD rates in China were 26.76/100 000, 0.59/100 000, 16.09/100 000, 14.61/100 000, and 1.48/100 000, respectively, and decreased by 8.94%, 45.33%, 49.12%, 50.98%, and 18.49%, respectively, compared with those in 1990. The burden of pancreatitis in China gradually increased with age, but was lower than that in the United States and globally. The DALY due to alcohol continually increased in China, the United States, and globally. Conclusion From 1990 to 2019, the burden of pancreatitis in China shows a decreasing trend and is lower than that in the United States and globally. However, the disease burden caused by alcohol and aging is increasing; therefore, effective measurements to alleviate the burden of pancreatitis in China are needed.

Citation： JIANG Mengke, LU Zongqing, ZHOU Wuming, LIU Wanjun, YANG Min. Analysis of the disease burden of pancreatitis in China from 1990 to 2019. Chinese Journal of Evidence-Based Medicine, 2022, 22(8): 869-875. doi: 10.7507/1672-2531.202203063 Copy

1.	中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021). 中华消化外科杂志, 2021, 20(7): 730-739.
2.	Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology, 2016, 16(2): 218-224.
3.	Sankaran SJ, Xiao AY, Wu LM, et al. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology, 2015, 149(6): 1490-1500.
4.	Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology, 2013, 144(6): 1252-1261.
5.	Pokras S, Ray M, Zheng S, et al. The short- and long-term burden of acute pancreatitis in the United States: a retrospective cohort study. Pancreas, 2021, 50(3): 330-340.
6.	GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1204-1222.
7.	GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1223-1249.
8.	GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159): 1789-1858.
9.	屈彦, 王天一, 杨津, 等. GBD数据库的数据提取方法与流程. 中国循证心血管医学杂志, 2019, 11(9): 1043-1046.
10.	孟令昊, 胥秋艳, 李科, 等. 1990~2019年中国女性宫颈癌疾病负担变化的分析. 中国循证医学杂志, 2021, 21(6): 648-653.
11.	王娜, 刘洁, 李晓东, 等. 中国1990~2019年结直肠癌疾病负担分析. 中国循证医学杂志, 2021, 21(5): 520-524.
12.	Naghavi M, Makela S, Foreman K, et al. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr, 2010, 8: 9.
13.	宇传华, 白建军. 社会人口指数(SDI)的概念及其应用. 公共卫生与预防医学, 2020, 31(1): 5-10.
14.	李辉章, 杜灵彬. Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用. 中华预防医学杂志, 2020, 54(8): 908-912.
15.	曾四清. Joinpoint回归模型及其在传染病流行趋势分析中的应用. 中国卫生统计, 2019, 36(5): 787-791.
16.	Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet. 2020, 396(10252): 726-734.
17.	Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas, 2006, 33(4): 323-330.
18.	Zheng Y, Zhou Z, Li H, et al. A multicenter study on etiology of acute pancreatitis in Beijing during 5 years. Pancreas, 2015, 44(3): 409-414.
19.	宁吉喆. 第七次全国人口普查主要数据情况. 中国统计, 2021, (5): 4-5.
20.	Roberts SE, Akbari A, Thorne K, et al. The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther, 2013, 38(5): 539-548.
21.	Ouyang G, Pan G, Liu Q, et al. The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. BMC Med, 2020, 18(1): 388.
22.	向斌, 张国培, 崔华永, 等. 大黄鼻饲对重症胰腺炎腹腔感染的疗效及对血管内皮糖萼的影响. 中国老年学杂志, 2021, 41(22): 4943-4946.
23.	马玉景, 郎晓猛, 康欣, 等. 不同中药注射液联合常规治疗用于重症急性胰腺炎疗效与安全性的网状Meta分析. 中草药, 2021, 52(24): 7583-7595.
24.	方婷, 庄一渝, 赵明明, 等. 重症急性胰腺炎病人应用芒硝外敷护理效果的系统评价. 护理研究, 2018, 32(1): 49-54.
25.	黄野, 李红昌, 孙文杰, 等. 大承气汤治疗重症急性胰腺炎多中心随机对照研究. 中国中西医结合杂志, 2019, 39(8): 949-953.
26.	Yang C, Wang T, Chen J, et al. Traditional Chinese medicine formulas alleviate acute pancreatitis: pharmacological activities and mechanisms. Pancreas, 2021, 50(10): 1348-1356.
27.	中国医师协会胰腺病专业委员会慢性胰腺炎专委会. 慢性胰腺炎诊治指南(2018, 广州). 中华消化内镜杂志, 2018, 35(11): 814-822.
28.	中华医学会急诊分会, 京津冀急诊急救联盟, 北京医学会急诊分会, 等. 急性胰腺炎急诊诊断及治疗专家共识. 中华急诊医学杂志, 2021, 30(2): 161-172.
29.	Crockett SD, Wani S, Gardner TB, et al. Amercan Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018, 154(4): 1096-1101.
30.	Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J, 2017, 5(2): 153-199.
31.	Weiss FU, Laemmerhirt F, Lerch MM. Etiology and risk factors of acute and chronic pancreatitis. Visc Med, 2019, 35(2): 73-81.
32.	Jin M, Bai X, Chen X, et al. A 16-year trend of etiology in acute pancreatitis: the increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. J Clin Lipidol, 2019, 13(6): 947-953.

1. 中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021). 中华消化外科杂志, 2021, 20(7): 730-739.
2. Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology, 2016, 16(2): 218-224.
3. Sankaran SJ, Xiao AY, Wu LM, et al. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology, 2015, 149(6): 1490-1500.
4. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology, 2013, 144(6): 1252-1261.
5. Pokras S, Ray M, Zheng S, et al. The short- and long-term burden of acute pancreatitis in the United States: a retrospective cohort study. Pancreas, 2021, 50(3): 330-340.
6. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1204-1222.
7. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1223-1249.
8. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159): 1789-1858.
9. 屈彦, 王天一, 杨津, 等. GBD数据库的数据提取方法与流程. 中国循证心血管医学杂志, 2019, 11(9): 1043-1046.
10. 孟令昊, 胥秋艳, 李科, 等. 1990~2019年中国女性宫颈癌疾病负担变化的分析. 中国循证医学杂志, 2021, 21(6): 648-653.
11. 王娜, 刘洁, 李晓东, 等. 中国1990~2019年结直肠癌疾病负担分析. 中国循证医学杂志, 2021, 21(5): 520-524.
12. Naghavi M, Makela S, Foreman K, et al. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr, 2010, 8: 9.
13. 宇传华, 白建军. 社会人口指数(SDI)的概念及其应用. 公共卫生与预防医学, 2020, 31(1): 5-10.
14. 李辉章, 杜灵彬. Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用. 中华预防医学杂志, 2020, 54(8): 908-912.
15. 曾四清. Joinpoint回归模型及其在传染病流行趋势分析中的应用. 中国卫生统计, 2019, 36(5): 787-791.
16. Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet. 2020, 396(10252): 726-734.
17. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas, 2006, 33(4): 323-330.
18. Zheng Y, Zhou Z, Li H, et al. A multicenter study on etiology of acute pancreatitis in Beijing during 5 years. Pancreas, 2015, 44(3): 409-414.
19. 宁吉喆. 第七次全国人口普查主要数据情况. 中国统计, 2021, (5): 4-5.
20. Roberts SE, Akbari A, Thorne K, et al. The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther, 2013, 38(5): 539-548.
21. Ouyang G, Pan G, Liu Q, et al. The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. BMC Med, 2020, 18(1): 388.
22. 向斌, 张国培, 崔华永, 等. 大黄鼻饲对重症胰腺炎腹腔感染的疗效及对血管内皮糖萼的影响. 中国老年学杂志, 2021, 41(22): 4943-4946.
23. 马玉景, 郎晓猛, 康欣, 等. 不同中药注射液联合常规治疗用于重症急性胰腺炎疗效与安全性的网状Meta分析. 中草药, 2021, 52(24): 7583-7595.
24. 方婷, 庄一渝, 赵明明, 等. 重症急性胰腺炎病人应用芒硝外敷护理效果的系统评价. 护理研究, 2018, 32(1): 49-54.
25. 黄野, 李红昌, 孙文杰, 等. 大承气汤治疗重症急性胰腺炎多中心随机对照研究. 中国中西医结合杂志, 2019, 39(8): 949-953.
26. Yang C, Wang T, Chen J, et al. Traditional Chinese medicine formulas alleviate acute pancreatitis: pharmacological activities and mechanisms. Pancreas, 2021, 50(10): 1348-1356.
27. 中国医师协会胰腺病专业委员会慢性胰腺炎专委会. 慢性胰腺炎诊治指南(2018, 广州). 中华消化内镜杂志, 2018, 35(11): 814-822.
28. 中华医学会急诊分会, 京津冀急诊急救联盟, 北京医学会急诊分会, 等. 急性胰腺炎急诊诊断及治疗专家共识. 中华急诊医学杂志, 2021, 30(2): 161-172.
29. Crockett SD, Wani S, Gardner TB, et al. Amercan Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018, 154(4): 1096-1101.
30. Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J, 2017, 5(2): 153-199.
31. Weiss FU, Laemmerhirt F, Lerch MM. Etiology and risk factors of acute and chronic pancreatitis. Visc Med, 2019, 35(2): 73-81.
32. Jin M, Bai X, Chen X, et al. A 16-year trend of etiology in acute pancreatitis: the increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. J Clin Lipidol, 2019, 13(6): 947-953.

Next Article
Accuracy and influencing factors of diabetes-related subscriptions on the WeChat platform

Chinese Journal of Evidence-Based Medicine

Analysis of the disease burden of pancreatitis in China from 1990 to 2019

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content